MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 64 filers reported holding MEI PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $337,000 | -21.8% | 127,650 | +27.6% | 0.02% | -5.9% |
| Q3 2018 | $431,000 | +9.4% | 100,000 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $394,000 | +13.5% | 100,000 | -40.3% | 0.02% | +6.2% |
| Q1 2018 | $347,000 | -1.4% | 167,462 | 0.0% | 0.02% | -15.8% |
| Q4 2017 | $352,000 | -17.6% | 167,462 | +5.2% | 0.02% | -24.0% |
| Q3 2017 | $427,000 | -15.8% | 159,162 | -25.0% | 0.02% | -24.2% |
| Q2 2017 | $507,000 | +4.3% | 212,262 | -29.2% | 0.03% | 0.0% |
| Q1 2017 | $486,000 | +3.8% | 300,000 | -7.7% | 0.03% | -2.9% |
| Q4 2016 | $468,000 | -29.1% | 325,000 | -13.3% | 0.03% | -49.3% |
| Q3 2016 | $660,000 | -7.6% | 375,000 | -28.6% | 0.07% | -19.3% |
| Q2 2016 | $714,000 | +5.8% | 525,000 | -2.1% | 0.08% | 0.0% |
| Q1 2016 | $675,000 | -11.2% | 536,110 | +12.9% | 0.08% | +69.4% |
| Q4 2015 | $760,000 | +287.8% | 475,000 | +280.0% | 0.05% | +96.0% |
| Q3 2015 | $196,000 | +14.6% | 125,000 | +25.0% | 0.02% | +25.0% |
| Q2 2015 | $171,000 | +17.1% | 100,000 | – | 0.02% | +11.1% |
| Q1 2015 | $146,000 | – | 0 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |